Anhui Anke Biotechnology (Group) Co., Ltd.

Anhui Anke Biotechnology (Group) Co., Ltd.

Share · CNE100000GY2 (XSHE)
Overview
AI-Powered Analysis
Fundamental Analysis
Find out what the numbers really say — before the market does
Analyze now
News Sentiment
Are today's headlines a buy signal or a red flag?
Analyze now
Buy / Hold / Sell
Should you Buy, Hold, or Sell? Get the AI verdict now.
Analyze now
Risk Assessment
Uncover hidden risks before they hit your portfolio.
Analyze now
Fair Value
Is this stock cheap, fairly priced, or overvalued?
Analyze now
Latest AI Analyses of Anhui Anke Biotechnology (Group) Co., Ltd.
No Price
Closing Price XSHE 29.04.2026: 8,95 CNY
29.04.2026 07:04
Current Prices from Anhui Anke Biotechnology (Group) Co., Ltd.
ExchangeTickerCurrencyLast TradePriceDaily Change
XSHE: SHENZHEN STOCK EXCHANGE
SHENZHEN STOCK EXCHANGE
300009.SZ
CNY
29.04.2026 07:04
8,95 CNY
0,04 CNY
+0,45 %
Share Float & Liquidity
Free Float 83,32 %
Shares Float 1,39 B
Shares Outstanding 1,67 B
Company Profile for Anhui Anke Biotechnology (Group) Co., Ltd. Share
Anhui Anke Biotechnology (Group) Co., Ltd. develops, produces, and markets pharmaceutical products in China and internationally. The company offers recombinant human growth hormone for injection under the Ansomone name; and recombinant human interferon alpha 2b lyophilized powder, liquid, and prefilled syringe for injection, as well as recombinant human interferon alpha 2b cream, eye drop, and suppository under the Anterferon name. It also provides anti-sperm antibody, semen leukocyte peroxidase staining, one-time semen processing, sperm hypo-osmotic staining, sperm life detection, sperm staining detection, sperm acrosin detection, sperm DNA fragmentation staining, and leptin and immunohistochemical diagnostic kits. In addition, the company offers adhesive plasters, oral solutions, topical preparations, and ointments; peptide APIs; beauty care and anti-aging products; and synthetic drugs in the form of oral powders, dripping pills, and tablets and capsules. Further, it provides autosomal, sex chromosome, autosomal and sex chromosome combination, and other kits, as well as paternity testing set packages; tumor biological immunotherapy products; and DNA testing professional services. The company was founded in 2000 and is based in Hefei, China.

Company Data

Name Anhui Anke Biotechnology (Group) Co., Ltd.
Company Anhui Anke Biotechnology (Group) Co., Ltd.
Website https://www.ankebio.com
Primary Exchange XSHE SHENZHEN STOCK EXCHANGE
ISIN CNE100000GY2
Asset Class Share
Sector Healthcare
Industry Biotechnology
CEO Jian Ping Yao
Market Capitalization 15 Mrd.
Country China
Currency CNY
Employees 2,6 T
Address AnkeBio Building, 230088 Hefei
IPO Date 2009-10-30
Dividends from 'Anhui Anke Biotechnology (Group) Co., Ltd.'
Ex-Date Dividend per Share
23.05.2025 0,15 CNY
17.01.2025 0,10 CNY
27.05.2024 0,25 CNY
19.05.2023 0,25 CNY
13.05.2022 0,20 CNY
14.05.2021 0,17 CNY
22.05.2020 0,15 CNY
09.05.2019 0,15 CNY
04.05.2018 0,15 CNY
18.05.2017 0,15 CNY

Stock Splits

Date Split
14.05.2021 6:5
22.05.2020 13:10
04.05.2018 7:5
18.05.2017 13:10
15.04.2016 13:10
17.04.2015 13:10
06.06.2014 6:5
13.06.2013 1243:1000
06.05.2011 5:4
12.05.2010 9:5

Ticker Symbols

Name Symbol
SHENZHEN STOCK EXCHANGE 300009.SZ
More Shares
Investors who hold Anhui Anke Biotechnology (Group) Co., Ltd. also have the following shares in their portfolio:
AERODI ROMA 23/33 MTN
AERODI ROMA 23/33 MTN Bond
COHERUS BIOSCIENCES INC
COHERUS BIOSCIENCES INC Share